{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:21:42Z","timestamp":1793042502392,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T00:00:00Z","timestamp":1712361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014978","name":"Hunan University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014978","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jep.2024.118160","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T21:34:24Z","timestamp":1712439264000},"page":"118160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"329","author":[{"given":"Min","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jep.2024.118160_bib1","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1021\/acs.jproteome.9b00249","article-title":"Lipidomics reveals similar changes in serum phospholipid signatures of overweight and obese pediatric subjects","volume":"18","author":"Anjos","year":"2019","journal-title":"J. Proteome Res."},{"issue":"5","key":"10.1016\/j.jep.2024.118160_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16031","article-title":"Assessing the hepatoprotective effects of hesperidin on liver-associated disorders in albino rats with experimentally induced obesity and type II diabetes: a histological and biochemical study","volume":"9","author":"Atta","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jep.2024.118160_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/bib\/bbl016","article-title":"Partial least squares: a versatile tool for the analysis of high-dimensional genomic data","volume":"8","author":"Boulesteix","year":"2007","journal-title":"Briefings Bioinf."},{"issue":"2","key":"10.1016\/j.jep.2024.118160_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/nu9020096","article-title":"Effects of natural products on fructose-induced nonalcoholic fatty liver disease (NAFLD)","volume":"9","author":"Chen","year":"2017","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jep.2024.118160_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00125-021-05611-3","article-title":"Associations of plasma glycerophospholipid profile with modifiable lifestyles and incident diabetes in middle-aged and older Chinese","volume":"65","author":"Chen","year":"2022","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.jep.2024.118160_bib6","first-page":"3","article-title":"Effect of Zuogui Jiangtang Prescription on inflammatory factors of NF-\u03baB signaling pathway in MKR rats with type 2 diabetes mellitus","volume":"24","author":"Cheng","year":"2013","journal-title":"Lishizhen Med. Mater. Med. Res."},{"issue":"5","key":"10.1016\/j.jep.2024.118160_bib7","first-page":"1307","article-title":"Effect of serum containing Zuogui Jiangtang Qinggan Formula on steatosis of HepG2 cells incubated with fatty acids","volume":"000","author":"Cheng","year":"2015","journal-title":"Chin. J. Gerontol."},{"key":"10.1016\/j.jep.2024.118160_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11306-016-1030-9","article-title":"Non-targeted UHPLC-MS metabolomic data processing methods: a comparative investigation of normalisation, missing value imputation, transformation and scaling","volume":"12","author":"Di Guida","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.jep.2024.118160_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123889","article-title":"Untargeted lipidomics-based study reveals the treatment mechanism of Qingxue Bawei tablets on atherosclerotic in ApoE(-\/-) mice","volume":"1229","author":"Du","year":"2023","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"7","key":"10.1016\/j.jep.2024.118160_bib10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nprot.2011.335","article-title":"Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry","volume":"6","author":"Dunn","year":"2011","journal-title":"Nat. Protoc."},{"issue":"11","key":"10.1016\/j.jep.2024.118160_bib11","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","article-title":"Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis","volume":"72","author":"En","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jep.2024.118160_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.jep.2024.118160_bib13","first-page":"4","article-title":"Guidelines for diagnosis and treatment of non-alcoholic fatty liver disease (revised 2010)","year":"2010","journal-title":"Chinese J. Liver Diseas."},{"key":"10.1016\/j.jep.2024.118160_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.593931","article-title":"A comprehensive update on the chylomicronemia syndrome","volume":"11","author":"Goldberg","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.jep.2024.118160_bib15","first-page":"585","article-title":"Effect of Zuogui Jiangtang Qingzhi Decoction on Visfatin signaling molecules in MKR mice with type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease","volume":"43","author":"Gou","year":"2023","journal-title":"J. Tradit. Chin. Med. Univ. Hunan"},{"issue":"11","key":"10.1016\/j.jep.2024.118160_bib16","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00228-023-03561-w","article-title":"Comparison of the efficacy and safety of hypoglycemic treatments in patients with non-alcoholic fatty liver disease and type-2 diabetes: a systematic review and Bayesian network analysis","volume":"79","author":"Guo","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"15","key":"10.1016\/j.jep.2024.118160_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/nu14153031","article-title":"The antidiabetic activities of neocryptotanshinone: screened by molecular docking and related to the modulation of PTP1B","volume":"14","author":"Hao","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jep.2024.118160_bib18","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s40200-023-01262-w","article-title":"A comprehensive review on the risks assessment and treatment options for Sarcopenia in people with diabetes","volume":"22","author":"Johri","year":"2023","journal-title":"J. Diabetes Metab. Disord."},{"issue":"8","key":"10.1016\/j.jep.2024.118160_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4254\/wjh.v12.i8.436","article-title":"Lipidomics in non-alcoholic fatty liver disease","volume":"12","author":"Kartsoli","year":"2020","journal-title":"World J. Hepatol."},{"issue":"2","key":"10.1016\/j.jep.2024.118160_bib20","article-title":"Anti-diabetic effect of quercetin in type 2 diabetes mellitus by regulating the microRNA-92b-3p\/EGR1 axis","volume":"74","author":"Ke","year":"2023","journal-title":"J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.jep.2024.118160_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28062570","article-title":"Nobiletin intake attenuates hepatic lipid profiling and oxidative stress in HFD-induced nonalcoholic-fatty-liver-disease mice","volume":"28","author":"Ke","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.jep.2024.118160_bib22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00125-009-1282-2","article-title":"Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations","volume":"52","author":"Kotronen","year":"2009","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.jep.2024.118160_bib23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1515\/cclm-2022-1105","article-title":"Clinical lipidomics in the era of the big data","volume":"61","author":"Kvasni\u010dka","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.jep.2024.118160_bib24","first-page":"12","article-title":"Pathogenesis of NASH and promising natural products","volume":"19","author":"Leng","year":"2021","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.jep.2024.118160_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1746-6148-6-6","article-title":"Ultrasound imaging in an experimental model of fatty liver disease and cirrhosis in rats","volume":"6","author":"Lessa","year":"2010","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.jep.2024.118160_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116468","article-title":"Banxia Xiexin decoction alleviates AS co-depression disease by regulating the gut microbiome-lipid metabolic axis","volume":"313","author":"Liao","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"32","key":"10.1016\/j.jep.2024.118160_bib27","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1021\/acs.jafc.1c03379","article-title":"Hepatic lipidomics analysis reveals the ameliorative effects of highland barley \u03b2-glucan on western diet-induced nonalcoholic fatty liver disease mice","volume":"69","author":"Liu","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"6","key":"10.1016\/j.jep.2024.118160_bib28","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s11571-022-09899-8","article-title":"Aberrant dynamic functional network connectivity in type 2 diabetes mellitus individuals","volume":"17","author":"Lyu","year":"2023","journal-title":"Cogn Neurodyn"},{"issue":"12","key":"10.1016\/j.jep.2024.118160_bib29","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1002\/fsn3.3729","article-title":"A narrative review on the role of hesperidin on metabolic parameters, liver enzymes, and inflammatory markers in nonalcoholic fatty liver disease","volume":"11","author":"Morshedzadeh","year":"2023","journal-title":"Food Sci. Nutr."},{"issue":"8","key":"10.1016\/j.jep.2024.118160_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ddr.21461","article-title":"Dose translation between laboratory animals and human in preclinical and clinical phases of drug development","volume":"79","author":"Nair","year":"2018","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jep.2024.118160_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.chroma.2016.02.054","article-title":"Comprehensive untargeted lipidomic analysis using core-shell C30 particle column and high field orbitrap mass spectrometer","volume":"1440","author":"Narv\u00e1ez-Rivas","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jep.2024.118160_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154661","article-title":"Diosgenin attenuates non-alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6-related fatty acid uptake","volume":"111","author":"Nie","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2024.118160_bib33","article-title":"Integrative lipidomics and metabolomics for system-level understanding of the metabolic syndrome in long-term treated HIV-infected individuals","volume":"12","author":"Olund","year":"2021","journal-title":"Front. Immunol."},{"issue":"9733","key":"10.1016\/j.jep.2024.118160_bib34","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","article-title":"Lipid-induced insulin resistance: unravelling the mechanism","volume":"375","author":"Samuel","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jep.2024.118160_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112357","article-title":"Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids","volume":"144","author":"Sarkar","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.jep.2024.118160_bib36","doi-asserted-by":"crossref","DOI":"10.1530\/EC-23-0212","article-title":"Lipidomics analysis of impaired glucose tolerance and type 2 diabetes mellitus in overweight or obese elderly adults","volume":"12","author":"Shao","year":"2023","journal-title":"Endocr Connect"},{"issue":"1","key":"10.1016\/j.jep.2024.118160_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40168-021-01097-8","article-title":"Novel insights into the genetically obese (ob\/ob) and diabetic (db\/db) mice: two sides of the same coin","volume":"9","author":"Suriano","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.jep.2024.118160_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.biochi.2023.09.020","article-title":"Impaired hepatic lipid metabolism and biomarkers in fatty liver disease","volume":"215","author":"Teixeira","year":"2023","journal-title":"Biochimie"},{"issue":"12","key":"10.1016\/j.jep.2024.118160_bib39","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat. Metab."},{"issue":"10","key":"10.1016\/j.jep.2024.118160_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/nu9101072","article-title":"Animal models of nonalcoholic fatty liver disease-A starter's guide","volume":"9","author":"Van Herck","year":"2017","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.jep.2024.118160_bib41","first-page":"8","article-title":"Effect of Zuogui Jiangtang Qinggan Prescription on glycolipid metabolism in MKR mice with type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease","volume":"29","author":"Wang","year":"2023","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"issue":"9","key":"10.1016\/j.jep.2024.118160_bib42","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.1096\/fj.202000678R","article-title":"Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD","volume":"34","author":"Weber","year":"2020","journal-title":"Faseb. J."},{"issue":"5","key":"10.1016\/j.jep.2024.118160_bib43","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1194\/jlr.D080283","article-title":"A novel assay for the introduction of the vinyl ether double bond into plasmalogens using pyrene-labeled substrates","volume":"59","author":"Werner","year":"2018","journal-title":"J. Lipid Res."},{"issue":"Pt 2","key":"10.1016\/j.jep.2024.118160_bib44","article-title":"Serum lipidomic profiling for liver cancer screening using surface-assisted laser desorption ionization MS and machine learning","volume":"268","author":"Wu","year":"2024","journal-title":"Talanta"},{"issue":"16","key":"10.1016\/j.jep.2024.118160_bib45","first-page":"4438","article-title":"Zuogui Gangtangqinggan prescription can improve the glycolipid metabolism of type 2 diabetes mellitus complicated with nonalcoholic fatty liver by regulating FoxO1\/MTP\/APOB signaling pathway","volume":"48","author":"Xiang","year":"2023","journal-title":"China J. Chin. Mater. Med."},{"key":"10.1016\/j.jep.2024.118160_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2023.109353","article-title":"A lipidomic study: nobiletin ameliorates hepatic steatosis through regulation of lipid alternation","volume":"118","author":"Yang","year":"2023","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.jep.2024.118160_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.apha.2019.08.002","article-title":"Astragaloside IV derived from Astragalus membranaceus: a research review on the pharmacological effects","volume":"87","author":"Zhang","year":"2020","journal-title":"Adv. Pharmacol."},{"issue":"6","key":"10.1016\/j.jep.2024.118160_bib48","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12076","article-title":"Astragaloside IV alleviates liver injury in type 2 diabetes due to promotion of AMPK\/mTOR-mediated autophagy","volume":"23","author":"Zhu","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.jep.2024.118160_bib49","first-page":"9","article-title":"Zuogui Jiangtang Qinggan Formula promotes intestinal mucosal barrier repair in mice with type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease by improving intestinal flora homeostasis","volume":"48","author":"Zou","year":"2023","journal-title":"J. Tradit. Chin. Med."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874124004598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874124004598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T21:59:29Z","timestamp":1716242369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874124004598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":49,"alternative-id":["S0378874124004598"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2024.118160","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2024.118160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"118160"}}